Portable Bioprinter in Ischemic Wound Therapy: a Pilot Study

The aim of the study was to develop a novel approach to treatment of non-healing wounds by using a portable Biogan bioprinter and an ink based on fibrin-gelatin hydrogel and spheroids derived from mesenchymal stromal cells (MSCs) from adipose tissue in a model of ischemic pig wound.

Materials and Methods. To simulate the wound, titanium sealing rings were used, which mechanically compressed the skin to create a local ischemic wound. A day after, the rings were removed, and the epidermis of the skin was excised. The wound was treated one day and 2 weeks after the wound infliction. For this purpose, a combined ink was applied to the wound surface using a portable Biogan bioprinter (the prototype was developed by the authors). An adapted passive mixer allowed uniform mixing of the bioink based on a fibrin-gelatin hydrogel and spheroids derived from human adipose MSCs. Wound closure rates were assessed over 36 days, followed by histological analysis.

Results. The use of inks based on fibrin-gelatin hydrogel and spheroids from adipose MSCs significantly accelerated healing, as evidenced by the reduction in the wound area compared to the control group and hydrogel-only group, as well as the complete restoration of all skin layers by day 36. The therapeutic effect of the developed approach was due to the spheroids in the bioinks and not to the hydrogel. The use of the developed mixer did not reduce the cell viability and ensured convenient ink application to the wound surface.

1. Vargas Guerrero M.G., Vonken L., Peters E., Lucchesi J., Arts J.J.C. Material technologies for improved diabetic foot ulcer (DFU) treatment: a questionnaire study of healthcare professionals' needs. Biomedicines 2024; 12(11): 2483, https://doi.org/10.3390/biomedicines12112483.
2. Waibel F.W.A., Uçkay I., Soldevila-Boixader L., Sydler C., Gariani K. Current knowledge of morbidities and direct costs related to diabetic foot disorders: a literature review. Front Endocrinol (Lausanne) 2024; 14: 1323315, https://doi.org/10.3389/fendo.2023.1323315.
3. Coruh A., Yontar Y. Application of split-thickness dermal grafts in deep partial- and full-thickness burns: a new source of auto-skin grafting. J Burn Care Res 2012; 33(3): e94–e100, https://doi.org/10.1097/BCR.0b013e31823499e9.
4. Lesher A.P., Curry R.H., Evans J., Smith V.A., Fitzgerald M.T., Cina R.A., Streck C.J., Hebra A.V. Effectiveness of Biobrane for treatment of partial-thickness burns in children. J Pediatr Surg 2011; 46(9): 1759–1763, https://doi.org/10.1016/j.jpedsurg.2011.03.070.
5. Gibbs S., Spiekstra S.W. Epidermal equivalent (EE) potency assay. In: Eskes C., van Vliet E., Maibach H. (editors). Alternatives for dermal toxicity testing. Springer, Cham; 2017, https://doi.org/10.1007/978-3-319-50353-0_20.
6. Normand J., Karasek M.A. A method for the isolation and serial propagation of keratinocytes, endothelial cells, and fibroblasts from a single punch biopsy of human skin. In Vitro Cell Dev Biol Anim 1995; 31(6): 447–455, https://doi.org/10.1007/BF02634257.
7. Kirsner R.S., Marston W.A., Snyder R.J., Lee T.D., Cargill D.I., Slade H.B. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2012; 380(9846): 977–985, https://doi.org/10.1016/S0140-6736(12)60644-8.
8. Rai V., Moellmer R., Agrawal D.K. Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer. Mol Biol Rep 2023; 50(2): 1913–1929, https://doi.org/10.1007/s11033-022-08107-4.
9. Zhong J., Wang H., Yang K., Wang H., Duan C., Ni N., An L., Luo Y., Zhao P., Gou Y., Sheng S., Shi D., Chen C., Wagstaff W., Hendren-Santiago B., Haydon R.C., Luu H.H., Reid R.R., Ho S.H., Ameer G.A., Shen L., He T.C., Fan J. Reversibly immortalized keratinocytes (iKera) facilitate re-epithelization and skin wound healing: potential applications in cell-based skin tissue engineering. Bioact Mater 2021; 9: 523–540, https://doi.org/10.1016/j.bioactmat.2021.07.022.
10. Benchaprathanphorn K., Muangman P., Chinaroonchai K., Namviriyachote N., Ampawong S., Angkhasirisap W., Kengkoom K., Viravaidya-Pasuwat K. Translational application of human keratinocyte-fibroblast cell sheets for accelerated wound healing in a clinically relevant type 2 diabetic rat model. Cytotherapy 2024; 26(4): 360–371, https://doi.org/10.1016/j.jcyt.2024.01.003.
11. Rodgers K., Jadhav S.S. The application of mesenchymal stem cells to treat thermal and radiation burns. Adv Drug Deliv Rev 2018; 123: 75–81, https://doi.org/10.1016/j.addr.2017.10.003.
12. Wu Q., Chen B., Liang Z. Mesenchymal stem cells as a prospective therapy for the diabetic foot. Stem Cells Int 2016; 2016: 4612167, https://doi.org/10.1155/2016/4612167.
13. Berlanga-Acosta J.A., Guillén-Nieto G.E., Rodríguez-Rodríguez N., Mendoza-Mari Y., Bringas-Vega M.L., Berlanga-Saez J.O., García Del Barco Herrera D., Martinez-Jimenez I., Hernandez-Gutierrez S., Valdés-Sosa P.A. Cellular senescence as the pathogenic hub of diabetes-related wound chronicity. Front Endocrinol (Lausanne) 2020; 11: 573032, https://doi.org/10.3389/fendo.2020.573032.
14. Dos Santos J.F., Borçari N.R., da Silva Araújo M., Nunes V.A. Mesenchymal stem cells differentiate into keratinocytes and express epidermal kallikreins: towards an in vitro model of human epidermis. J Cell Biochem 2019; 120(8): 13141–13155, https://doi.org/10.1002/jcb.28589.
15. Guillamat-Prats R. The role of MSC in wound healing, scarring and regeneration. Cells 2021; 10(7): 1729, https://doi.org/10.3390/cells10071729.
16. Cao Y., Yan J., Dong Z., Wang J., Jiang X., Cui T., Huang Y., Liu H. Adipose-derived mesenchymal stem cells are ideal for the cell-based treatment of refractory wounds: strong potential for angiogenesis. Stem Cell Rev Rep 2024; 20(1): 313–328, https://doi.org/10.1007/s12015-023-10641-y.
17. Almalki S.G. Adipose-derived mesenchymal stem cells and wound healing: potential clinical applications in wound repair. Saudi Med J 2022; 43(10): 1075–1086, https://doi.org/10.15537/smj.2022.43.10.20220522.
18. Ravi M., Paramesh V., Kaviya S.R., Anuradha E., Solomon F.D. 3D cell culture systems: advantages and applications. J Cell Physiol 2015; 230(1): 16–26, https://doi.org/10.1002/jcp.24683.
19. Gorkun A.A., Revokatova D.P., Zurina I.M., Nikishin D.A., Bikmulina P.Y., Timashev P.S., Shpichka A.I., Kosheleva N.V., Kolokoltsova T.D., Saburina I.N. The duo of osteogenic and angiogenic differentiation in ADSC-derived spheroids. Front Cell Dev Biol 2021; 9: 572727, https://doi.org/10.3389/fcell.2021.572727.
20. Pleguezuelos-Beltrán P., Gálvez-Martín P., Nieto-García D., Marchal J.A., López-Ruiz E. Advances in spray products for skin regeneration. Bioact Mater 2022; 16: 187–203, https://doi.org/10.1016/j.bioactmat.2022.02.023.
21. Nuutila K., Katayama S., Laitinen A., Siltanen A., Patrikoski M., Valtonen J., Kankainen M., Kerkelä E., Kaartinen T., Juteau S., Korhonen M., Vuola J., Kankuri E. ATMP-classified, scalable, autologous cell spray for the treatment of skin wounds and assessment of its effects on wound healing clinically and on a molecular level. Burns 2023; 49(5): 1144–1156, https://doi.org/10.1016/j.burns.2022.09.006.
22. Albanna M., Binder K.W., Murphy S.V., Kim J., Qasem S.A., Zhao W., Tan J., El-Amin I.B., Dice D.D., Marco J., Green J., Xu T., Skardal A., Holmes J.H., Jackson J.D., Atala A., Yoo J.J. In situ bioprinting of autologous skin cells accelerates wound healing of extensive excisional full-thickness wounds. Sci Rep 2019; 9(1): 1856, https://doi.org/10.1038/s41598-018-38366-w.
23. Harkin D.G., Dawson R.A., Upton Z. Optimized delivery of skin keratinocytes by aerosolization and suspension in fibrin tissue adhesive. Wound Repair Regen 2006; 14(3): 354–363, https://doi.org/10.1111/j.1743-6109.2006.00132.x.
24. Pazhouhnia Z., Beheshtizadeh N., Namini M.S., Lotfibakhshaiesh N. Portable hand-held bioprinters promote in situ tissue regeneration. Bioeng Transl Med 2022; 7(3): e10307, https://doi.org/10.1002/btm2.10307.
25. Singer A.J., Toussaint J., Chung W.T., McClain S.A., Clark R.A.F., Asculai E., Geblinger D., Rosenberg L. Development of a contaminated ischemic porcine wound model and the evaluation of bromelain based enzymatic debridement. Burns 2018; 44(4): 896–904, https://doi.org/10.1016/j.burns.2017.07.022.

Revokatova D.P., Khristidis Y.I., Fayzullin A.L., Ershov B.P., Larionov D.I., Nesterenko I.V., Shpichka A.I., Timashev P.S. Portable Bioprinter in Ischemic Wound Therapy: a Pilot Study. Sovremennye tehnologii v medicine 2026; 18(1): 23, https://doi.org/10.17691/stm2026.18.1.02